The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
Open accessAbstract
Purpose: To update the 2000 American Society of Clinical Oncology guideline on the use of hematopoietic colony-stimulating factors (CSF). Update Methodology: The Update Committee completed a review and analysis of pertinent data published from 1999 through September 2005. Guided by the 1996 ASCO clinical outcomes criteria, the Update Committee formulated recommendations based on improvements in survival, quality of life, toxicity reduction and cost-effectiveness. Recommendations: The 2005 Update Committee agreed unanimously that reduction in febrile neutropenia (FN) is an important clinical outcome that justifies the use of CSFs, regardless of impact on other factors, when the risk of FN is approximately 20% and no other equally effective regimen that does not require CSFs is available. Primary prophylaxis is recommended for the prevention of FN in patients who are at high risk based on age, medical history, disease characteristics, and myelotoxicity of the chemotherapy regimen. CSF use allows a modest to moderate increase in dose-density and/or dose-intensity of chemotherapy regimens. Dose-dense regimens should only be used within an appropriately designed clinical trial or if supported by convincing efficacy data. Prophylactic CSF for patients with diffuse aggressive lymphoma aged 65 years and older treated with curative chemotherapy (CHOP or more aggressive regimens) should be given to reduce the incidence of FN and infections. Current recommendations for the management of patients exposed to lethal doses of total body radiotherapy, but not doses high enough to lead to certain death due to injury to other organs, includes the prompt administration of CSF or pegylated G-CSF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.163 · Cited by 2,426
Self-citationvon der Maase, H., Hansen, S. W., Roberts, J. T., Dogliotti, L., Oliver, T., Moore, M. J., Bodrogi, I., Albers, P., Knuth, A., Lippert, C. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3068 · Cited by 2,279
Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A., & Miller, T. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304083281404 · Cited by 2,149
Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
Henderson, I. C., Berry, D. A., Demetri, G. D., Cirrincione, C. T., Goldstein, L. J., Martino, S., Ingle, J. N., Cooper, M. R., Hayes, D. F., Tkaczuk, K. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.063 · Cited by 1,294
Self-citationKlastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
Canellos, G. P., Anderson, J. R., Propert, K. J., Nissen, N., Cooper, M. R., Henderson, E. S., Green, M. R., Gottlieb, A., & Peterson, B. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272102 · Cited by 1,148
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
von Pawel, J., Schiller, J. H., Shepherd, F. A., Fields, S. Z., Kleisbauer, J. P., Chrysson, N. G., Stewart, D. J., Clark, P. I., Palmer, M. C., Depierre, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.658 · Cited by 968
Fossella, F., Pereira, J. R., von Pawel, J., Pluzanska, A., Gorbounova, V., Kaukel, E., Mattson, K. V., Ramlau, R., Szczęsna, A., Fidias, P., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.046 · Cited by 939
Waselenko, J. K., MacVittie, T. J., Blakely, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00015 · Cited by 766
Self-citationForastiere, A. A., Metch, B., Schuller, D. E., Ensley, J. F., Hutchins, L. F., Triozzi, P., Kish, J. A., McClure, S., VonFeldt, E., & Williamson, S. K. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1245 · Cited by 752
Northfelt, D. W., Dezube, B. J., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., Du Mond, C., Mamelok, R. D., & Henry, D. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2445 · Cited by 649
Rothenberg, M. L., Oza, A. M., Bigelow, R. H., Berlin, J. D., Marshall, J. L., Ramanathan, R. K., Hart, L. L., Gupta, S., Garay, C. A., Burger, B. G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.126 · Cited by 646
Chan, S., Friedrichs, K., Noel, D., Pintér, T., Van Belle, S., Vorobiof, D., Duarte, R., Gil Gil, M., Bodrogi, I., Murray, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2341 · Cited by 641
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Roth, B. J., Johnson, D. H., Einhorn, L. H., Schacter, L. P., Cherng, N. C., Cohen, H. J., Crawford, J., Randolph, J. A., Goodlow, J. L., & Broun, G. O. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.282 · Cited by 556
Self-citationWozniak, A. J., Crowley, J. J., Balcerzak, S. P., Weiss, G. R., Spiridonidis, C. H., Baker, L. H., Albain, K. S., Kelly, K., Taylor, S. A., Gandara, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2459 · Cited by 555
Self-citationTalcott, J. A., Siegel, R. D., Finberg, R., & Goldman, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.316 · Cited by 545
Santoro, A., Tursz, T., Mouridsen, H., Verweij, J., Steward, W., Somers, R., Buesa, J., Casali, P., Spooner, D., & Rankin, E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1537 · Cited by 526
Vogel, C. L., Wojtukiewicz, M. Z., Carroll, R. R., Tjulandin, S. A., Barajas-Figueroa, L. J., Wiens, B. L., Neumann, T. A., & Schwartzberg, L. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.102 · Cited by 482
Self-citationAntman, K. H., Crowley, J. J., Balcerzak, S. P., Rivkin, S. E., Weiss, G. R., ELIAS, A. D., Natale, R. B., Cooper, R. M., Barlogie, B., & Trump, D. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1276 · Cited by 478
Ross, P., Nicolson, M., Cunningham, D., Valle, J., Seymour, M., Harper, P., Price, T., Anderson, H., Iveson, T., Hickish, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.105 · Cited by 475
Pettengell, R., Gurney, H., Radford, J., Deakin, D., James, R., Wilkinson, P., Kane, K., Bentley, J., & Crowther, D. (1992) · Blood · doi:10.1182/blood.v80.6.1430.1430 · Cited by 440
Rougier, P., Bugat, R., Douillard, J. Y., Culine, S., Suc, E., Brunet, P., Becouarn, Y., Ychou, M., Marty, M., Extra, J. M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.251 · Cited by 434
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.671 · Cited by 431
Velasquez, W. S., McLaughlin, P., Tucker, S., Hagemeister, F. B., Swan, F., Rodriguez, M. A., Romaguera, J., Rubenstein, E., & Cabanillas, F. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1169 · Cited by 430
O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Erlichman, C., Shepherd, L., Moertel, C. G., Kocha, W. I., Pazdur, R., Wieand, H. S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.295 · Cited by 417
Löwenberg, B., van Putten, W., Theobald, M., Gmür, J., Verdonck, L., Sonneveld, P., Fey, M., Schouten, H., de Greef, G., Ferrant, A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025406 · Cited by 386
Nabholtz, J.-M., Falkson, C., Campos, D., Szanto, J., Martin, M., Chan, S., Pienkowski, T., Zaluski, J., Pinter, T., Krzakowski, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.040 · Cited by 384
Poon, M. A., O'Connell, M. J., Wieand, H. S., Krook, J. E., Gerstner, J. B., Tschetter, L. K., Levitt, R., Kardinal, C. G., & Mailliard, J. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.11.1967 · Cited by 375
Dixon, D. O., Neilan, B., Jones, S. E., Lipschitz, D. A., Miller, T. P., Grozea, P. N., & Wilson, H. E. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.3.295 · Cited by 360
Nichols, C. R., Catalano, P. J., Crawford, E. D., Vogelzang, N. J., Einhorn, L. H., & Loehrer, P. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1287 · Cited by 348
Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., et al. (1997) · Blood · doi:10.1182/blood.v90.12.4710 · Cited by 332
Bookman, M. A., Malmström, H., Bolis, G., Gordon, A., Lissoni, A., Krebs, J. B., & Fields, S. Z. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3345 · Cited by 321
Clark, O. A. C., Lyman, G. H., Castro, A. A., Clark, L. G. O., & Djulbegovic, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.645 · Cited by 310
Self-citationCrivellari, D., Bonetti, M., Castiglione-Gertsch, M., Gelber, R. D., Rudenstam, C.-M., Thürlimann, B., Price, K. N., Coates, A. S., Hürny, C., Bernhard, J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1412 · Cited by 291
Sonneveld, P., de Ridder, M., van der Lelie, H., Nieuwenhuis, K., Schouten, H., Mulder, A., van Reijswoud, I., Hop, W., & Lowenberg, B. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2530 · Cited by 280
Skarlos, D. V., Samantas, E., Kosmidis, P., Fountzilas, G., Angelidou, M., Palamidas, P. H., Mylonakis, N., Provata, A., Papadakis, E., Klouvas, G., et al. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058931 · Cited by 274
Larson, R. A., Dodge, R. K., LINKER, C. A., Stone, R. M., Powell, B. L., Lee, E. J., Schulman, P., Davey, F. R., Frankel, S. R., Bloomfield, C. D., et al. (1998) · PubMed · doi:10.1182/blood.v92.5.1556 · Cited by 269
Self-citationThe Hematologist and Radiation Casualties
Dainiak, N., Waselenko, J. K., Armitage, J. O., MacVittie, T. J., & Farese, A. M. (2003) · Hematology · doi:10.1182/asheducation-2003.1.473 · Cited by 245
Self-citationARMITAGE, J. O., & POTTER, J. F. (1984) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1984.tb02020.x · Cited by 230
Self-citationThatcher, N., Girling, D. J., Hopwood, P., Sambrook, R. J., Qian, W., Stephens, R. J., & for the Medical Research Council Lung Cancer Working Party (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.395 · Cited by 224
Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J. C., Thomas, J., Bron, D., Rosti, G., Somers, R., Zagonel, V, et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.27 · Cited by 220
The granulocyte—Macrophage colony stimulating factors
Metcalf, D. (1985) · Cell · doi:10.1016/0092-8674(85)90004-2 · Cited by 215
Gelman, R. S., & Taylor, S. G. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.12.1404 · Cited by 203
Ringdén, O., Labopin, M., Gorin, N.-C., Le Blanc, K., Rocha, V., Gluckman, E., Reiffers, J., Arcese, W., Vossen, J. M., Jouet, J.-P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.102 · Cited by 191
Vose, J. M., Crump, M., Lazarus, H., Emmanouilides, C., Schenkein, D., Moore, J., Frankel, S., Flinn, I., Lovelace, W., Hackett, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.040 · Cited by 187
Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma
Gill, P. S., Tulpule, A., Espina, B. M., Cabriales, S., Bresnahan, J., Ilaw, M., Louie, S., Gustafson, N. F., Brown, M. A., Orcutt, C., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1876 · Cited by 185
Timmer-Bonte, J. N., de Boo, T. M., Smit, H. J., Biesma, B., Wilschut, F. A., Cheragwandi, S. A., Termeer, A., Hensing, C. A., Akkermans, J., Adang, E. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7955 · Cited by 185
Farese, A. M., Hunt, P., Grab, L. B., & MacVittie, T. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118652 · Cited by 181
Dees, E. C., O'reilly, S., Goodman, S. N., Sartorius, S., Levine, M. A., Jones, R. J., Grochow, L. B., Donehower, R. C., & Fetting, J. H. (2000) · Cancer Investigation · doi:10.3109/07357900009012191 · Cited by 180
Garcia-Carbonero, R., Mayordomo, J. I., Tornamira, M. V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.31 · Cited by 177
Dillman, R., Davis, R., Green, M. R., Weiss, R. B., Gottlieb, A., Caplan, S. N., Kopel, S., Preisler, H., McIntyre, O. R., & Schiffer, C. A. (1991) · Blood · doi:10.1182/blood.v78.10.2520.2520 · Cited by 176
Self-citationDoorduijn, J. K., van der Holt, B., van Imhoff, G. W., van der Hem, K. G., Kramer, M. H. H., van Oers, M. H. J., Ossenkoppele, G. J., Schaafsma, M. R., Verdonck, L. F., Verhoef, G. E. G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.076 · Cited by 168
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Bohlius, J., Herbst, C., Reiser, M., Schwarzer, G., & Engert, A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003189.pub4 · Cited by 157
Gómez, H., Mas, L., Casanova, L., Pen, D. L., Santillana, S., Valdivia, S., Otero, J., Rodriguez, W., Carracedo, C., & Vallejos, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2352 · Cited by 155
Zinzani, P. L., Storti, S., Zaccaria, A., Moretti, L., Magagnoli, M., Pavone, E., Gentilini, P., Guardigni, L., Gobbi, M., Fattori, P. P., et al. (1999) · PubMed · Cited by 153
Relling, M. V., Boyett, J. M., Blanco, J. G., Raimondi, S. C., Behm, F. G., Sandlund, J. T., Rivera, G. K., Kun, L. E., Evans, W. E., & Pui, C. (2003) · Blood · doi:10.1182/blood-2002-08-2405 · Cited by 151
Vaughn, D. J., Malkowicz, S. B., Zoltick, B. H., Mick, R., Ramchandani, P., Holroyde, C. P., Armstead, B., Fox, K. R., & Wein, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.255 · Cited by 149
Morrison, V. A., Picozzi, V. J., Scott, S., Pohlman, B. L., Dickman, E., Lee, M. W., Lawless, G. D., Kerr, R. O., Caggiano, V., Delgado, D., et al. (2001) · Clinical Lymphoma · doi:10.3816/clm.2001.n.011 · Cited by 144
Meyer, R. M., Browman, G. P., Samosh, M., Benger, A. M., Bryant‐Lukosius, D., Wilson, W. E., Frank, G. L., Leber, B. F., Sternbach, M. S., & Foster, G. A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2386 · Cited by 141
Glisson, B. S., Murphy, B. A., Frenette, G., Khuri, F. R., & Forastiere, A. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1593 · Cited by 136
Salmon, S. E., Crowley, J. J., Grogan, T. M., Finley, P. R., Pugh, R. P., & Barlogie, B. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2405 · Cited by 132
Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients
Darmon, M., Azoulay, É., Alberti, C., Fieux, F., Moreau, D., Gall, J. L., & Schlemmer, B. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1528-7 · Cited by 125
Sung, L., Nathan, P. C., Lange, B. J., Beyene, J., & Buchanan, G. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.106 · Cited by 117
Epidemiology of Febrile Neutropenia
Lyman, G. H., & Kuderer, N. M. (2003) · Supportive Cancer Therapy · doi:10.3816/sct.2003.n.002 · Cited by 116
Self-citationSiena, S., Piccart, M. J., Holmes, F. A., Glaspy, J. A., Hackett, J. R., & Renwick, J. (2003) · PubMed · Cited by 101
Papaldo, P., Lopez, M., Marolla, P., Cortesi, E., Antimi, M., Terzoli, E., Vici, P., Barone, C. A., Ferretti, G., Cosimo, S. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.099 · Cited by 96
Berghmans, T., Paesmans, M., Lafitte, J., Mascaux, C., Meert, A., Jacquy, C., Burniat, A., Steels, E., Vallot, F., & Jp, S. (2002) · Supportive Care in Cancer · doi:10.1007/s00520-001-0312-5 · Cited by 93
Catlett, J., & Alving, B. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-2-200201150-00011 · Cited by 89
Weaver, C. H., Schulman, K. A., Wilson-Relyea, B. J., Birch, R., West, W. H., & Buckner, C. D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.43 · Cited by 85
Timmer-Bonte, J. N. H., Adang, E., Smit, H. J. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3281 · Cited by 85
Farese, A. M., Williams, D. E., Seiler, F. R., & MacVittie, T. J. (1993) · Blood · doi:10.1182/blood.v82.10.3012.3012 · Cited by 83
Chrischilles, E. A., Delgado, D. J., Stolshek, B. S., Lawless, G. D., Fridman, M., Carter, W. B., & for the Oncology Practice Pattern Study Working Group (2002) · Cancer Control · doi:10.1177/107327480200900303 · Cited by 77
Neelis, K. J., Dubbelman, Y. D., Qingliang, L., Thomas, G. R., Eaton, D., & Wagemaker, G. (1997) · PubMed · Cited by 75
MacVittie, T. J., Farese, A. M., Hérodin, F., Grab, L. B., Baum, C. M., & McKearn, J. (1996) · Blood · doi:10.1182/blood.v87.10.4129.bloodjournal87104129 · Cited by 67
Evans, S. R., Krown, S. E., Testa, M. A., Cooley, T. P., & Roenn, J. H. V. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.038 · Cited by 65
Ilan, Y., Nagler, A., Zeira, E., Adler, R., Slavin, S., & Shouval, D. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702571 · Cited by 52
Berghmans, T., Paesmans, M., Lafitte, J. J., Mascaux, C., Meert, A. P., & Sculier, J. P. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00082-x · Cited by 50
Kouroukis, C. T., Browman, G. P., Esmail, R., & Meyer, R. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-2-200201150-00012 · Cited by 46
Kalish, L. A., Kyle, R. A., Hahn, R. G., Tormey, D. C., Oken, M. M., & Gertz, M. A. (1995) · American Journal of Clinical Oncology · doi:10.1097/00000421-199512000-00003 · Cited by 41
Nash, R., Schuening, F., Seidel, K. D., Appelbaum, F. R., Boone, T., Deeg, H. J., Graham, T., Hackman, R. C., Sullivan-Pepe, M., & Storb, R. F. (1994) · Blood · doi:10.1182/blood.v83.7.1963.1963 · Cited by 33
Farese, A. M., Casey, D. B., Vigneulle, R. M., Siegel, N. R., Finn, R. F., Klover, J. A., Smith, W. G., McKearn, J. P., & MacVittie, T. J. (2001) · Stem Cells · doi:10.1634/stemcells.19-6-514 · Cited by 27
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
James, N. D., Sydes, M. R., Clarke, N. W., Mason, M. D., Dearnaley, D. P., Spears, M. R., Ritchie, A. W. S., Parker, C. C., Russell, J. M., Attard, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01037-5 · Cited by 1,978
Stewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
Metadata
- Authors
- Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., Demetri, G., Desch, C. E., Pizzo, P. A., Schiffer, C. A., Schwartzberg, L., Somerfield, M. R., Somlo, G., Wade, J. C., Wade, J. L., Winn, R. J., Wozniak, A. J., & Wolff, A. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-07-01
- Volume
- 24
- Issue
- 19
- Pages
- 3187-3205
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2142195688
- Cited by
- 1,636
- References
- 93
- FWCI
- 61.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.